AU5066098A - A whole blood/mitogen assay for the early detection of a subject with cancer and kit - Google Patents

A whole blood/mitogen assay for the early detection of a subject with cancer and kit

Info

Publication number
AU5066098A
AU5066098A AU50660/98A AU5066098A AU5066098A AU 5066098 A AU5066098 A AU 5066098A AU 50660/98 A AU50660/98 A AU 50660/98A AU 5066098 A AU5066098 A AU 5066098A AU 5066098 A AU5066098 A AU 5066098A
Authority
AU
Australia
Prior art keywords
cancer
kit
subject
whole blood
early detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU50660/98A
Inventor
Tamar Jehuda Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shiloov Medical Technologies Ltd
Original Assignee
Shiloov Medical Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/755,413 external-priority patent/US6322989B1/en
Priority claimed from US08/755,287 external-priority patent/US20020006608A1/en
Application filed by Shiloov Medical Technologies Ltd filed Critical Shiloov Medical Technologies Ltd
Publication of AU5066098A publication Critical patent/AU5066098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57415—Specifically defined cancers of breast
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57449—Specifically defined cancers of ovaries
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AU50660/98A 1996-11-22 1997-11-21 A whole blood/mitogen assay for the early detection of a subject with cancer and kit Abandoned AU5066098A (en)

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US75524096A 1996-11-22 1996-11-22
US75541296A 1996-11-22 1996-11-22
US75523296A 1996-11-22 1996-11-22
US75541496A 1996-11-22 1996-11-22
US75541596A 1996-11-22 1996-11-22
US08755414 1996-11-22
US08/755,413 US6322989B1 (en) 1991-11-25 1996-11-22 Whole blood/mitogen assay for the early detection of a subject with ovarian or breast cancer and kit
US08755412 1996-11-22
US08755232 1996-11-22
US08/755,287 US20020006608A1 (en) 1991-11-25 1996-11-22 Whole blood/mitogen assay for the early detection of a subject infected with hepatitis c virus and kit
US08755415 1996-11-22
US08755287 1996-11-22
US08755413 1996-11-22
US08755240 1996-11-22
PCT/IL1997/000381 WO1998022825A2 (en) 1996-11-22 1997-11-21 A whole blood/mitogen assay for the early detection of a subject with cancer and kit

Publications (1)

Publication Number Publication Date
AU5066098A true AU5066098A (en) 1998-06-10

Family

ID=27569910

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50660/98A Abandoned AU5066098A (en) 1996-11-22 1997-11-21 A whole blood/mitogen assay for the early detection of a subject with cancer and kit

Country Status (6)

Country Link
EP (1) EP0943095A2 (en)
JP (1) JP2001504233A (en)
AU (1) AU5066098A (en)
CA (1) CA2272924A1 (en)
IL (1) IL130074A0 (en)
WO (1) WO1998022825A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19681033D2 (en) 1995-11-16 1999-03-18 Michael W Dahm Method for the quantification of tumor cells in a body fluid and suitable test kits
DE19804372A1 (en) 1998-02-04 1999-08-05 Michael W Dr Dr Dahm Method for the quantitative determination of tumor cells in a body fluid and suitable test kits
US20060063190A1 (en) * 2004-09-22 2006-03-23 Tripath Imaging, Inc Methods and compositions for evaluating breast cancer prognosis
US20090011410A1 (en) * 2004-10-20 2009-01-08 Masato Mitsuhashi Method for tailoring administration of drugs by quantitation of mrna
CN101855367A (en) 2007-11-14 2010-10-06 日立化成工业株式会社 Enhanced fc receptor-mediated tumor necrosis factor superfamily mrna expression in peripheral blood leukocytes in patients with rheumatoid arthritis
US11028443B2 (en) 2015-08-31 2021-06-08 Showa Denko Materials Co., Ltd. Molecular methods for assessing urothelial disease

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0203403B1 (en) * 1985-05-01 1992-10-28 Asahi Kasei Kogyo Kabushiki Kaisha A cloned t cell capable of recognizing tumors and a t cell antigen receptor
CA1305912C (en) * 1987-06-22 1992-08-04 Richard J. Albertini Detection of lymphocyte amplification
PT643838E (en) * 1991-11-25 2000-10-31 Shiloov Medical Technologies L METHOD FOR THE DETECTION OF ANTIBODIES IN SERONEGATIVE INDIVIDUALS
AU3435293A (en) * 1992-01-21 1993-08-03 Ludwig Institute For Cancer Research Method for determining cytolytic T cell precursors
KR950701391A (en) * 1992-04-30 1995-03-23 원본미기재 Method for detecting T cell antigen receptor gene expression
DE19515219A1 (en) * 1995-04-28 1996-10-31 Gabriele Dr Pecher Assay for tumour-specific cytotoxic T cells

Also Published As

Publication number Publication date
EP0943095A2 (en) 1999-09-22
CA2272924A1 (en) 1998-05-28
JP2001504233A (en) 2001-03-27
WO1998022825A3 (en) 1998-08-06
WO1998022825A2 (en) 1998-05-28
IL130074A0 (en) 2000-02-29

Similar Documents

Publication Publication Date Title
AU640162B2 (en) Blood separation and analyte detection techniques
AU4269589A (en) Assay and sensing means for determining analyte
AU7686094A (en) Method, reagent and kit for the detection of fecal occult blood
EP0944642A4 (en) Dioxetane labeled probes and detection assays employing the same
AU2245092A (en) Blood constituent determination based on differential spectral analysis
AU2925997A (en) Analysis of complex mixtures
AU5166198A (en) Opaque reaction matrix for the analysis of whole blood
AU629616B2 (en) Slide fastener and fastener elements therefor
AU2261597A (en) Electrochemiluminescence enzyme assay
AU1165097A (en) Sampling and assay device
GB9727296D0 (en) Assay and kit for determining the condition of cells
AU8347391A (en) Simultaneous assay for detecting one or more analytes
AU7738598A (en) Sample-collecting and assay device
AU7736796A (en) Chemiluminescent assay methods and devices for detecting target analytes
AU5066098A (en) A whole blood/mitogen assay for the early detection of a subject with cancer and kit
AU8023794A (en) Reduction of background interferences in the molybdate-dye protein assay
AU8408998A (en) Assay for total and direct bilirubin
AU2667197A (en) Stabilized preparations of human troponins and modifications thereof, diagnostic assay methods and assay kits
AU7713498A (en) Immunoassay for the detection of cancer
AUPN024994A0 (en) Assay and peptides for use therein
AU1678499A (en) Detection of analytes
AU1288499A (en) Methods of identifying and diagnosing inflammatory bowel disease or subtypes with the nramp locus
AU2372597A (en) Quantitative detection of analytes on immunochromatographic strips
AU4937093A (en) Conjugate for the detection and/or assay of a biological compound
AU8271998A (en) Methods of disease detection